Skip to main content

Animations

MJFF Publications

1731 - 1740 of 6422 Results
Title
Year
  • Year
  • 2022
  • 2023
  • 2022
  • 2023
  • 2023
  • 2022
  • 2023
  • 2023
  • 2023
  • 2021
  • Summary Details
    OPEN
    Title: Combining Multimodal Biomarkers to Guide Deep Brain Stimulation Programming in Parkinson Disease
    Journal Name: Neuromodulation: Technology at the Neural Interface
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.neurom.2022.01.017
    Citation Count: 49
  • Summary Details
    OPEN
    Title: Editorial: Brain stimulation in cognition and disease
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2023.1213272
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Motor Response With Apomorphine Sublingual Film and Levodopa in Patients With OFF Episodes
    Journal Name: Neurodegenerative Disease Management
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.2217/nmt-2022-0038
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Specific Detection of Physiological S129 Phosphorylated α-Synuclein in Tissue Using Proximity Ligation Assay
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3233/jpd-213085
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Self-Image in Women with Parkinson’s Disease
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.3233/jpd-230017
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Soluble Epoxide Hydrolase Derived Linoleic Acid Oxylipins, Small Vessel Disease Markers, and Neurodegeneration in Stroke
    Journal Name: Journal of the American Heart Association
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1161/jaha.122.026901
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Challenges and innovations in brain PET analysis of neurodegenerative disorders: a mini-review on partial volume effects, small brain region studies, and reference region selection
    Journal Name: Frontiers in Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnins.2023.1293847
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Predicting cognitive decline in a low‐dimensional representation of brain morphology
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/alz.081611
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Fas gene dosage tunes the extent of lymphoproliferation and T cell differentiation in lupus
    Journal Name: Clinical Immunology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.clim.2023.109874
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Genome-Wide Polygenic Risk Score Identifies Individuals at Elevated Parkinson’s Disease Risk (4286)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.96.15_supplement.4286
    Citation Count: 3
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.